Press Releases | Health Monitor Liechtenstein

Jun. 9, 2025

Liechtenstein Reaffirms Global Leadership in Stability and Philanthropy

EIN Presswire

Jul. 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

GlobeNewswire, Inc.

Apr. 15, 2025

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

GlobeNewswire, Inc.

Feb. 2, 2026

EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg

GlobeNewswire, Inc.

Mar. 17, 2025

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion

GlobeNewswire, Inc.

Feb. 24, 2026

Fajon na Svetu OZN za človekove pravice: Molk ob kršitvah ni nevtralnost — je sokrivda

Government of Slovenia

Owner: Slovenian Government

Government of Slovenia

Gov't Institution

Owned By	Slovenian Government
Year Founded	1990
Website	www.vlada.si
Domain Registration Year	1998
Access Type	open
Publication Location	Slovenia, Ljubljana
Owner Country	Slovenia

We welcome your feedback!
If you have comments or corrections, let us know.

Feb. 19, 2026

Slovenia and Switzerland: Strong economic partners and good friends

Government of Slovenia

Owner: Slovenian Government

Government of Slovenia

Gov't Institution

Owned By	Slovenian Government
Year Founded	1990
Website	www.vlada.si
Domain Registration Year	1998
Access Type	open
Publication Location	Slovenia, Ljubljana
Owner Country	Slovenia

We welcome your feedback!
If you have comments or corrections, let us know.

Jan. 28, 2026

bonyf – A Year of Certification, Innovation and Commercial Acceleration

EIN Presswire

Dec. 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

GlobeNewswire, Inc.

Jan. 19, 2026

CEO Insight Releases New 2026 Issue Examining Trust, Governance and Global Connectivity

EIN Presswire

Feb. 9, 2026

Regulating Artificial Intelligence in a Fragmented World — RegulatingAI Podcast

EIN Presswire

Dec. 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

GlobeNewswire, Inc.

Oct. 16, 2025

bonyf AG receives the EU-MDR Certification Class IIa for PerioCream

EIN Presswire

Nov. 4, 2025

Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea

GlobeNewswire, Inc.

Jan. 14, 2026

The European Magazine Releases Its Winter 2026 Edition

EIN Presswire

Sep. 29, 2025

Dental Prosthetics Market Size to Grow from USD 9.12 Billion in 2024 to USD 15.88 Billion by 2034, at a 5.7% CAGR

EIN Presswire

Jan. 5, 2026

SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities

GlobeNewswire, Inc.

$Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)$

Jul. 21, 2025

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

GlobeNewswire, Inc.

Apr. 28, 2025

Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

GlobeNewswire, Inc.

Jun. 20, 2025

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

GlobeNewswire, Inc.